Allergic Conjunctivitis
📧 Sign up to get email alerts when something new happens for Allergic Conjunctivitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-04-09Clinical Trial Update: Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in the Treatment of Allergic Conjunctivitis [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of an anti-allergy drug used with a contact lens for allergic conjunctivitis; the study ha…
-
CLINICAL_TRIALS trial_result · 2009-04-09Clinical Trial Update: Evaluation of Efficacy and Safety of an Anti-Allergy Drug With a Contact Lens in Allergic Conjunctivitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of an anti-allergy drug delivered via a contact lens for allergic conjunctivitis c…
-
CLINICAL_TRIALS trial_result · 2008-04-09Clinical Trial Update: A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis [Phase 4]
Phase 4 clinical trial comparing olopatadine and fluticasone in allergic conjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: Montelukast as a Controller of Atopic Syndrome [Phase 4]
Phase 4 clinical trial evaluating montelukast for control of atopic syndrome has completed, studying its effects in seasonal allergic rhinit…
-
CLINICAL_TRIALS trial_result · 2007-03-05Clinical Trial Update: Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study [Phase 2]
Open-label Phase 2 pilot study evaluating topical tacrolimus 0.03% ointment for intractable allergic conjunctivitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-11-07Clinical Trial Update: Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan [Phase 4]
A Phase 4 trial evaluated whether orally administered superfine beta-1,3-Glucan reduces cedar pollen–induced allergic symptoms, including al…